Nalaganje...
SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
Introduction Hypercalcemia is a rare complication of myeloproliferative neoplasms. As a result, the underlying mechanisms and optimal treatment options remain under investigation. We present a case of hypercalcemia in post-essential thrombocythemia (ET) related myelofibrosis that was responsive to t...
Shranjeno v:
| izdano v: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Endocrine Society
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6551918/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-499 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|